September 2026
The CAR-T therapies for blood cancers market generated USD 8.09 billion in 2026, with prominent CAR-T therapies for blood cancers market companies including Novartis AG, Gilead Sciences, Inc. (Kite Pharma), Bristol Myers Squibb Company (Celgene/Juno Therapeutics), Johnson & Johnson (Legend Biotech Corporation).
December 2025
The global lentivirus manufacturing for advanced therapies market grows with rising demand for viral vectors supporting gene therapy, CAR-T development, and advanced treatments.
September 2026
The global blood ketone meter market size was evaluated at USD 558.54 million in 2026 and is predicted to hit around USD 1026.85 million by 2035, growing at a CAGR of 7.00%.
September 2026
The global peripheral blood mononuclear cells market size was evaluated at USD 350.42 billion in 2026 and is predicted to hit around USD 842.89 billion by 2035, growing at a CAGR of 10.26%.
September 2026
The global blood meal market size is estimated to hit around USD 1.83 billion by 2035 increasing from USD 1.33 billion in 2026, with a CAGR of 3.56%.
September 2026
The global capillary blood collection devices market size is projected to surpass around USD 3.74 billion by 2034 increasing from USD 2.44 billion in 2026, with a CAGR of 5.49%.
September 2026
The global non-invasive blood pressure monitors market size is expected to hit around USD 63.18 billion by 2035 from USD 34.61 billion in 2025, with a CAGR of 6.93%.
September 2026
The global blood plasma derivatives market size is projected to hit around USD 122.37 billion by 2035 from USD 58.36 billion in 2026 with a CAGR of 8.59%.
September 2026
The RNA editing therapies market expands with clinical progress in precision therapeutics, rare disease solutions, and gene-based medicine.
September 2026
The global artificial blood vessels market size reached USD 20.09 billion in 2026, and is projected to surpass around USD 34.56 billion by 2034 with a notable CAGR of 6.29%
September 2026
The blood transfusion devices market size is calculated at USD 6.79 billion in 2026 and is projected to hit around USD 11.43 billion by 2035 with a CAGR of 5.97%.
September 2026
The global blood preparation market size was valued at USD 57.31 billion in 2026 and is expected to hit around USD 96.27 billion by 2035, growing at a CAGR of 5.92% from 2026 to 2035.
September 2026
The blood screening market size stood at USD 4.3 billion in 2026, with major blood screening market companies including Abbott Laboratories, Roche Diagnostics, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc.
September 2026
The global blood culture test market size is valued at USD 8.40 billion in 2026 and is projected to hit around USD 21.79 billion by 2035 with a CAGR of 11.23%.
September 2026
The global blood cancer diagnostics market size is estimated to hit around USD 22.55 billion by 2035 increasing from USD 12.46 billion in 2026, with a CAGR of 6.83%.
September 2026
The global oral obesity therapies market size was evaluated at USD 4.70 billion in 2026 and is predicted to hit around USD 9.34 billion by 2035, growing at a CAGR of 7.94%.
September 2026
The global blood group typing market size was evaluated at USD 2.63 billion in 2026 and is predicted to hit around USD 5.52 billion by 2035, growing at a CAGR of 8.60%.
September 2026
The global vacuum blood collection tube market size is estimated to hit around USD 4.22 billion by 2034 increasing from USD 3.26 billion in 2026, with a CAGR of 3.27%.
September 2026
The global bovine blood plasma derivatives market size was evaluated at USD 1.49 billion in 2026 and is predicted to hit around USD 3.00 billion by 2034, growing at a CAGR of 9.15%.
September 2026
The b-cell maturation antigen (BCMA) targeted therapies market size reached USD 6.62 billion in 2026, with leading B-Cell Maturation Antigen (BCMA) Targeted Therapies Market companies including Bristol Myers Squibb, Johnson & Johnson, GSK plc, Amgen Inc., Regeneron Pharmaceuticals, Inc.
September 2026
The global in vivo CAR-T therapy market size was evaluated at USD 861.25 million in 2026 and is predicted to hit around USD 10,841.07 million by 2035, growing at a CAGR of 32.50%.
September 2026
The blood pressure monitoring devices market is projected to grow from USD 2.46 billion in 2026 to USD 5.02 billion by 2035, at a CAGR of 8.26%. The increasing prevalence of hypertension and preventive healthcare awareness has boosted the usage of blood pressure monitoring devices.
September 2026
The global blood platelets market size was estimated at USD 6.38 billion in 2026 and is projected to attain around USD 9.86 billion by 2033 with a CAGR of 5.59%.
September 2026
The global blood transfusion diagnostics market size was evaluated at USD 5.58 billion in 2026 and is predicted to hit around USD 8.79 billion by 2034, growing at a CAGR of 5.84%.
September 2026
The global blood gas and electrolyte analyzers market size was valued at USD 3.19 billion in 2026 and is predicted to surge around USD 4.55 billion by 2034, at a CAGR of 4.54%.
September 2026
The U.S. radiopharmaceutical therapies market size is estimated to hit around USD 7.70 billion by 2035 increasing from USD 1.92 billion in 2025, with a CAGR of 14.9%%.
September 2026
The global RFID blood refrigerators and freezers market size is estimated to hit around USD 1,151.02 million by 2034 increasing from USD 425.68 million in 2024, with a CAGR of 13.24%.
September 2026
The global blood glucose monitoring market size is evaluated at USD 17.97 billion in 2026 and is predicted to hit around USD 26.59 billion by 2035, growing at a CAGR of 4.45%.
September 2026
By Payal Rabde - Aug 2026 - the blood filtration and purification market was valued at USD 3.97 billion in 2025, expanding at a CAGR of 7.95% by 2035.
September 2026
The blood clot retrieval devices market size reached USD 2.4 billion in 2026, with leading blood clot retrieval devices market companies including AngioDynamics, Terumo Co., Johnson and Johnson.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com